Biochemical and functional alterations associated with hypercholesterolemia in platelets from hypertensive patients.
Hypercholesterolemia and hypertension are two of the major risk factors associated with increased atherosclerotic vascular disease. An abnormal platelet function is one of the mechanisms proposed to participate in atherogenesis. This study was undertaken to find out whether hypercholesterolemia in hypertensive patients can change platelet lipid composition and reactivity. Twenty-nine untreated hypertensive patients were distributed into 3 age, body mass index and blood pressure-matched groups according to their plasma cholesterol levels (normal, borderline or elevated, group NC, BC and HC respectively). Their platelet lipid composition, cytosolic Ca2+ concentration, cyclic AMP content and aggregating response to ADP and collagen were determined. Platelet from group HC patients were characterized by reduced cyclic AMP content (evaluated in the presence and absence of a platelet phosphodiesterase inhibitor) and aggregating responses to ADP and collagen, increased palmitic acid content and decreased arachidonic, eicosapentaenoic and docosatetraenoic and pentaenoic acid content, resulting in a lowered polyunsaturated to saturated fatty acid ratio (P less than 0.001). In contrast, platelet cytosolic Ca2+ concentration, DPH steady-state anisotropy and cholesterol to phospholipid molar ratio were not significantly changed. This indicates that hypercholesterolemia is accompanied in hypertensive patients by marked changes in platelet fatty acid composition, cyclic AMP content and response to aggregating agents. These changes, which clearly differ from those induced by in vitro cholesterol loading, could reflect not only the balance between LDL and HDL stimulation but also an adaptation to hemodynamic perturbations.
Mazeaud
M M
MM
Pharmacology, CNRS 1482, Necker Medical School, Paris, France.
Driss
F
F
Le Quan Sang
K H
KH
Duranthon
V
V
Levenson
J
J
Simon
A
A
Devynck
M A
MA
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000328:Adult; D001792:Blood Platelets / Q000737:chemistry* / Q000502:physiology; D002118:Calcium / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D003094:Collagen / Q000494:pharmacology; D000242:Cyclic AMP / Q000032:analysis; D005227:Fatty Acids / Q000032:analysis; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood* / Q000150:complications; D006973:Hypertension / Q000150:complications*; D008055:Lipids / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects
D005227:Fatty Acids; D008055:Lipids; D000244:Adenosine Diphosphate; D003094:Collagen; D002784:Cholesterol; D000242:Cyclic AMP; D002118:Calcium